Advanced Diagnostics underlines ultrasound future hopes with name change:
This article was originally published in Clinica
Advanced Diagnostics (ADI), which develops products based on its diffractive ultrasound technology, has changed its name to Advanced Imaging Technologies (AIT). The Preston, Washington based-company believes that although diagnostic use of diffractive ultrasound will remain its key focus, it also has potential in instrument guidance and treatment planning. Diffractive ultrasound, which uses "through wave" transmission of sound to create detailed mages of soft tissue, has been used to create AIT's first product using the technology, the Avera breast imaging system. Avera provides real-time imaging without the need for radiation or painful compression, the company says.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.